ExonHit Therapeutics has announced a supply and service provider agreement to combine Affymetrix' GeneChip® microarray platform and ExonHit's alternative RNA splicing technologies and expertise.

Genomatix Software GmbH has announced that it has achieved GeneChip-compatible™ status for several products with the Affymetrix Inc. GeneChip ® microarray platform and that it has joined Affymetrix ...

GENE CHIPS GAIN RESOLUTION Affymetrix has constantly expanded the number of DNA types that can be detected by a single GeneChip. The first product in its catalogue contained 16, 000 probe types ...

NEW YORK (CBS.MW) -- Affymetrix Inc. said Monday the U.S. Food and Drug Administration has approved its GeneChip system 3000Dx, an instrumentation system to analyze in vitro diagnostic microarrays ...

Affymetrix(R) Launches Next-Generation microRNA Solution GeneChip(R) miRNA 2.0 Array offers the most comprehensive view of non-coding RNA available SANTA CLARA, Calif., Feb 28, 2011 (BUSINESS WIRE) -- ...

Contacts. Affymetrix Inc. Andrew Noble, 408-731-5571 (Media) Associate Director, Corporate Communications Doug Farrell, 408-731-5285 (Investors) Vice President, Investor Relations ...

NOTE: Affymetrix, the Affymetrix logo and GeneChip(R) are registered trademarks owned or used by Affymetrix Inc. CONTACT: Affymetrix Inc. Andrew Noble, 408-731-5571 (Media) ...

Biotechnology stocks were headed into negative territory in early trading Friday, with shares of Affymetrix losing more than a third of their value after the maker of genetic research technology ...

Affymetrix, the Affymetrix logo, GeneChip, QuantiGene, SensationPlus, and all other trademarks are the property of Affymetrix, Inc. All other trademarks are the property of their respective owners.

XRGenomics uses Affymetrix’s GeneChip ® U133 Plus 2.0 array. According to Affymetrix, the array offers complete coverage of the Human Genome U133 Set plus 6,500 additional genes for analysis of ...

Thermo Fisher Scientific Inc. will buy Affymetrix Inc. in a roughly $1.3 billion cash deal that would boost its biogenetic analysis portfolio, the company said Friday.

Affymetrix Inc. of Santa Clara won the race Thursday to market a single gene chip packed with fragments from each of the 35,000 known genes that make up the human genome. But two other Bay area ...